[PDF][PDF] Ewing sarcoma: current management and future approaches through collaboration
N Gaspar, DS Hawkins, U Dirksen, IJ Lewis… - J Clin …, 2015 - researchgate.net
Ewing sarcoma (ES) is an aggressive sarcoma of bone and soft tissue occurring at any age
with a peak incidence in adolescents and young adults. The treatment of ES relies on a …
with a peak incidence in adolescents and young adults. The treatment of ES relies on a …
Neuroblastoma (Peripheral neuroblastic tumours)
R Luksch, MR Castellani, P Collini… - Critical reviews in …, 2016 - Elsevier
Peripheral neuroblastic tumours (PNTs), a family of tumours arising in the embryonal
remnants of the sympathetic nervous system, account for 7–10% of all tumours in children. In …
remnants of the sympathetic nervous system, account for 7–10% of all tumours in children. In …
Adult Wilms' tumor: A monoinstitutional experience and a review of the literature
M Terenziani, F Spreafico, P Collini, L Piva, D Perotti… - Cancer, 2004 - Wiley Online Library
BACKGROUND The authors reviewed their institutional experience regarding adult patients
with Wilms' tumor (WT) to assess their clinical characteristics and compliance with respect to …
with Wilms' tumor (WT) to assess their clinical characteristics and compliance with respect to …
Interleukin 2 with anti-GD2 antibody ch14. 18/CHO (dinutuximab beta) in patients with high-risk neuroblastoma (HR-NBL1/SIOPEN): a multicentre, randomised, phase …
R Ladenstein, U Pötschger, D Valteau-Couanet… - The Lancet …, 2018 - thelancet.com
Background Immunotherapy with the chimeric anti-GD2 monoclonal antibody dinutuximab,
combined with alternating granulocyte-macrophage colony-stimulating factor and …
combined with alternating granulocyte-macrophage colony-stimulating factor and …
Busulfan and melphalan versus carboplatin, etoposide, and melphalan as high-dose chemotherapy for high-risk neuroblastoma (HR-NBL1/SIOPEN): an international …
R Ladenstein, U Pötschger, ADJ Pearson… - The lancet …, 2017 - thelancet.com
Background High-dose chemotherapy with haemopoietic stem-cell rescue improves event-
free survival in patients with high-risk neuroblastoma; however, which regimen has the …
free survival in patients with high-risk neuroblastoma; however, which regimen has the …
Mutation-independent anaplastic lymphoma kinase overexpression in poor prognosis neuroblastoma patients
L Passoni, L Longo, P Collini, AML Coluccia, F Bozzi… - Cancer research, 2009 - AACR
Anaplastic lymphoma kinase (ALK) is a receptor tyrosine kinase predominantly expressed in
the developing nervous system. Recently, mutated ALK has been identified as a major …
the developing nervous system. Recently, mutated ALK has been identified as a major …
[PDF][PDF] High response rate to cisplatin/etoposide regimen in childhood low-grade glioma
M Massimino, F Spreafico, G Cefalo… - Journal of clinical …, 2002 - researchgate.net
Purpose: The aim of this study was to avoid radio-therapy and to induce an objective
response in children with low-grade glioma (LGG) using a simple chemotherapy regimen …
response in children with low-grade glioma (LGG) using a simple chemotherapy regimen …
[HTML][HTML] Children with cancer in the time of COVID‐19: an 8‐week report from the six pediatric onco‐hematology centers in Lombardia, Italy
A Ferrari, M Zecca, C Rizzari, F Porta… - Pediatric blood & …, 2020 - ncbi.nlm.nih.gov
To the Editor: This report assesses the impact of the COVID-19 pandemic on pediatric
cancer patients over an 8-week period elapsing from the day of the Italian outbreak …
cancer patients over an 8-week period elapsing from the day of the Italian outbreak …
Phase I trial and pharmacokinetics of fenretinide in children with neuroblastoma
A Garaventa, R Luksch, MSL Piccolo, E Cavadini… - Clinical Cancer …, 2003 - AACR
Abstract Purpose: Fenretinide (4HPR), a synthetic retinoid, induces apoptosis in
neuroblastoma cells. A Phase I study in children with neuroblastoma was designed to …
neuroblastoma cells. A Phase I study in children with neuroblastoma was designed to …
[PDF][PDF] Hyperfractionated accelerated radiotherapy in the Milan strategy for metastatic medulloblastoma
L Gandola, M Massimino, G Cefalo… - Journal of Clinical …, 2009 - researchgate.net
Hyperfractionated Accelerated Radiotherapy in the Milan Strategy for Metastatic Medulloblastoma
Page 1 Hyperfractionated Accelerated Radiotherapy in the Milan Strategy for Metastatic …
Page 1 Hyperfractionated Accelerated Radiotherapy in the Milan Strategy for Metastatic …